Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
149.41
-10.15 (-6.36%)
At close: Apr 3, 2025, 4:00 PM
148.83
-0.58 (-0.39%)
Pre-market: Apr 4, 2025, 4:10 AM EDT
Inspire Medical Systems Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Inspire Medical Systems stock have an average target of 226.7, with a low estimate of 190 and a high estimate of 260. The average target predicts an increase of 51.73% from the current stock price of 149.41.
Analyst Consensus: Buy
* Price targets were last updated on Feb 11, 2025.
Analyst Ratings
The average analyst rating for Inspire Medical Systems stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $250 → $235 | Strong Buy | Maintains | $250 → $235 | +57.29% | Feb 11, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $260 | Buy | Reiterates | $260 | +74.02% | Feb 11, 2025 |
| Baird | Baird | Buy Maintains $252 → $248 | Buy | Maintains | $252 → $248 | +65.99% | Feb 11, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $198 → $195 | Hold | Maintains | $198 → $195 | +30.51% | Feb 11, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $230 → $220 | Buy | Maintains | $230 → $220 | +47.25% | Feb 11, 2025 |
Financial Forecast
Revenue This Year
968.61M
from 802.80M
Increased by 20.65%
Revenue Next Year
1.14B
from 968.61M
Increased by 17.49%
EPS This Year
2.21
from 1.75
Increased by 26.31%
EPS Next Year
3.26
from 2.21
Increased by 47.46%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.0B | 1.2B | 1.4B | ||
| Avg | 968.6M | 1.1B | 1.3B | ||
| Low | 921.2M | 1.1B | 1.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 25.3% | 24.6% | 25.7% | ||
| Avg | 20.7% | 17.5% | 16.4% | ||
| Low | 14.7% | 10.0% | 6.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.34 | 4.67 | 6.53 | ||
| Avg | 2.21 | 3.26 | 4.70 | ||
| Low | 2.06 | 2.65 | 3.79 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 33.8% | 111.4% | 100.4% | ||
| Avg | 26.3% | 47.5% | 44.1% | ||
| Low | 17.6% | 19.7% | 16.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.